NEU 1.68% $12.91 neuren pharmaceuticals limited

it is difficult to know what their intention is for lodging this...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,255 Posts.
    lightbulb Created with Sketch. 317
    it is difficult to know what their intention is for lodging this notice:

    1. they published an article late last year stating that they had been reducing exposure to Neuren as they felt the chance of PMS phase 2 success was low. At this point, they did not issue a notice when ceasing to be the substantial holder which is fine as Neuren is NZ incorporated and the notice is not mandatory
    2. based on today's notice, they were above the significant shareholding threshold prior to 17th July meaning they bought back more NEU shares post PMS result. but they chose not to issue the notice when becoming the substantial shareholder again.
    3. today they chose to issue the notice for ceasing to be the substantial holder but for what purpose?
    Last edited by ashgood123: 19/07/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.